Literature DB >> 25500218

Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings.

Ebrahim Haroon1, Jennifer C Felger1, Bobbi J Woolwine1, Xiangchuan Chen2, Samir Parekh3, James R Spivey3, Xiaoping P Hu2, Andrew H Miller1.   

Abstract

Inflammation-induced alterations in central nervous system (CNS) metabolism have focused on glutamate. At excessive concentrations, glutamate is toxic to glia and neurons, and inflammatory cytokines have been shown to influence glutamate turnover by blocking glutamate reuptake and increasing glutamate release. Increased glutamate has also been found in depression, a disorder associated with increased inflammation. Data by our group have shown increased glutamate as measured by magnetic resonance spectroscopy (MRS) in basal ganglia and dorsal anterior cingulate cortex of patients administered the inflammatory cytokine interferon (IFN)-alpha. Given data that increasing age is associated with an exaggerated CNS inflammatory response, we examined whether older age (>55years) would be associated with a greater IFN-alpha-induced increase in CNS glutamate. Using a longitudinal design, 31 patients with hepatitis C virus (HCV) underwent MRS, blood sampling for inflammatory markers, and behavioral assessments before (Visit 1) and after 4weeks (Visit 2) of either IFN-alpha (n=17) or no treatment (n=14). Older patients treated with IFN-alpha exhibited a significantly greater increase in glutamate from Visit 1 to Visit 2 as reflected by the glutamate/creatine ratio (Glu/Cr) in left basal ganglia compared to older controls and younger IFN-alpha-treated and untreated subjects. In addition, increased Glu/Cr in older but not younger IFN-alpha-treated and untreated patients was associated with increased tumor necrosis factor, reduced motivation as measured by the Multidimensional Fatigue Inventory and increased choice movement time on the Cambridge Neuropsychological Test Automated Battery. Taken together, these preliminary data support the notion that older age may interact with inflammation to exaggerate the effects of inflammatory stimuli on CNS glutamate and behavior.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Basal ganglia; Cytokine; Glutamate; IFN-alpha; Inflammation; Motivation; Psychomotor speed; TNF

Mesh:

Substances:

Year:  2014        PMID: 25500218      PMCID: PMC4414678          DOI: 10.1016/j.bbi.2014.12.004

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  21 in total

Review 1.  Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.

Authors:  Cagri Yüksel; Dost Öngür
Journal:  Biol Psychiatry       Date:  2010-08-21       Impact factor: 13.382

2.  Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate.

Authors:  D Piani; K Frei; K Q Do; M Cuénod; A Fontana
Journal:  Neurosci Lett       Date:  1991-12-09       Impact factor: 3.046

3.  Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes.

Authors:  Rejane G Tavares; Carla I Tasca; Candice E S Santos; Letícia B Alves; Lisiane O Porciúncula; Tatiana Emanuelli; Diogo O Souza
Journal:  Neurochem Int       Date:  2002-06       Impact factor: 3.921

4.  Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration.

Authors:  Lucile Capuron; Giuseppe Pagnoni; Daniel F Drake; Bobbi J Woolwine; James R Spivey; Ronald J Crowe; John R Votaw; Mark M Goodman; Andrew H Miller
Journal:  Arch Gen Psychiatry       Date:  2012-10

5.  IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.

Authors:  Ebrahim Haroon; Bobbi J Woolwine; Xiangchuan Chen; Thaddeus W Pace; Samir Parekh; James R Spivey; Xiaoping P Hu; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2014-01-31       Impact factor: 7.853

Review 6.  Review: microglia of the aged brain: primed to be activated and resistant to regulation.

Authors:  D M Norden; J P Godbout
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

7.  Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.

Authors:  C L Raison; A S Borisov; B J Woolwine; Breanne Massung; G Vogt; A H Miller
Journal:  Mol Psychiatry       Date:  2008-06-03       Impact factor: 15.992

8.  Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder.

Authors:  Jonathan Savitz; Wayne C Drevets; Chelsey M Smith; Teresa A Victor; Brent E Wurfel; Patrick S F Bellgowan; Jerzy Bodurka; T Kent Teague; Robert Dantzer
Journal:  Neuropsychopharmacology       Date:  2014-07-30       Impact factor: 7.853

Review 9.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

Authors:  Claudio Franceschi; Judith Campisi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06       Impact factor: 6.053

10.  The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

Authors:  E M Smets; B Garssen; B Bonke; J C De Haes
Journal:  J Psychosom Res       Date:  1995-04       Impact factor: 3.006

View more
  20 in total

1.  Inflammation, Depression, and Slow Gait: A High Mortality Phenotype in Later Life.

Authors:  Patrick J Brown; Steven P Roose; Jun Zhang; Melanie Wall; Bret R Rutherford; Hilsa N Ayonayon; Meryl A Butters; Tamara Harris; Anne B Newman; Suzanne Satterfield; Eleanor M Simonsick; Kristine Yaffe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-09-20       Impact factor: 6.053

Review 2.  Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression.

Authors:  Malcolm P Forbes; Adrienne O'Neil; Melissa Lane; Bruno Agustini; Nick Myles; Michael Berk
Journal:  Drugs Aging       Date:  2021-04-29       Impact factor: 3.923

3.  Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study.

Authors:  Mandakh Bekhbat; Zhihao Li; Namrataa D Mehta; Michael T Treadway; Michael J Lucido; Bobbi J Woolwine; Ebrahim Haroon; Andrew H Miller; Jennifer C Felger
Journal:  Mol Psychiatry       Date:  2022-08-04       Impact factor: 13.437

Review 4.  Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications.

Authors:  Mandakh Bekhbat; Michael T Treadway; Jennifer C Felger
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 5.  Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Authors:  Ebrahim Haroon; Andrew H Miller; Gerard Sanacora
Journal:  Neuropsychopharmacology       Date:  2016-09-15       Impact factor: 7.853

Review 6.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

7.  Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.

Authors:  Timothy B Meier; Wayne C Drevets; Brent E Wurfel; Bart N Ford; Harvey M Morris; Teresa A Victor; Jerzy Bodurka; T Kent Teague; Robert Dantzer; Jonathan Savitz
Journal:  Brain Behav Immun       Date:  2015-11-04       Impact factor: 7.217

8.  Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression.

Authors:  Mandakh Bekhbat; Karen Chu; Ngoc-Anh Le; Bobbi J Woolwine; Ebrahim Haroon; Andrew H Miller; Jennifer C Felger
Journal:  Psychoneuroendocrinology       Date:  2018-09-06       Impact factor: 4.905

9.  Inflammatory markers are associated with decreased psychomotor speed in patients with major depressive disorder.

Authors:  David R Goldsmith; Ebrahim Haroon; Bobbi J Woolwine; Moon Y Jung; Evanthia C Wommack; Philip D Harvey; Michael T Treadway; Jennifer C Felger; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2016-04-01       Impact factor: 7.217

10.  Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression.

Authors:  J C Felger; Z Li; E Haroon; B J Woolwine; M Y Jung; X Hu; A H Miller
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.